Traders brace for S&P 500’s busiest CPI day since March 2023

Image source: Adobe Stock

Traders brace for S&P 500’s busiest CPI day since March 2023. 📑 The S&P 500 faces its largest implied move ahead of a CPI report in nearly a year, with a potential 1% move in either direction on January 15. Robust jobs data and soaring bond yields add to the tension. Yahoo Finance reports.

🌌 QuantumShift: Quantum stocks see reckoning as Nvidia comments spark whiplash. Yahoo Finance reports.

🚀 AIFront: OpenAI on Monday laid out its vision for artificial intelligence development in the U.S., saying the country needs outside investment and supportive regulation to stay ahead of China in the race for the nascent technology. Reuters reports.

⬇️ ModernaDown: Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion. CNBC reports.

⚔️ MarketBattle: iPhone market share dips to 18% in 2024, as domestic Chinese brands like Huawei and Xiaomi gain ground. Benzinga reports.

🛍️ ShopSlip: Big-name retailers posted largely better-than-expected early holiday results on Monday, but their shares fell as Wall Street came away unimpressed. CNBC reports.

➕ J&JPlus: Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the market for brain disease treatments. Reuters reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Benzinga reports.

1. $:NMHI: Nature's Miracle Holding
Total gain: +142.47%

2. $:HEES: H&E Equipment Services
Total gain: +105.39%

3. $:STAF: Staffing 360 Solutions
Total gain: +71.86%

4. $:PIII: P3 Health Partners
Total gain: +46.06%

5. $:ADD: Color Star Technology
Total gain: +37.15%

* Analyzing the markets with Richie Naso, a Wall Street veteran of over 40 years and former member of the NYSE.

BOND YIELDS AND THE STOCK MARKET

During the week of January 6 to January 10, 2025, U.S. stock markets experienced notable declines, influenced by economic data and sector-specific developments.

Economic Indicators:

- Treasury Yields: The 10-year Treasury yield increased to 4.772%, the highest since November 2023, influencing borrowing costs and investor sentiment.

- Federal Reserve Outlook: The strong employment data has led traders to anticipate that the Federal Reserve may maintain its current interest rates longer than previously expected, affecting market expectations.

In summary, the first full trading week of 2025 was marked by declines across major U.S. stock indexes, driven by robust employment data that tempered expectations for near-term interest rate cuts, alongside sector-specific developments influencing individual stock performances.

The closing price of the top three market percent gainers trading near or above $3 on January 13.

*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time

1. $PHIO: Phio Pharmaceuticals
Total gain: 282.20%
The company announced pathologic responses for patients enrolled in the second cohort, which includes two patients with a complete response, or 100% tumor clearance. Benzinga reports.

2. $SLRX: Salarius Pharmaceuticals
Total gain: 133.20%
The company and Decoy Therapeutics announced the signing of a definitive agreement under which Decoy Therapeutics will merge with a wholly owned subsidiary of Salarius Pharmaceuticals, subject to the closing conditions outlined in the definitive agreement. Benzinga reports.

3. $VRME: VerifyMe
Total gain: 61.96%
The stock appeared to be moving on no notable news.

Time (ET) / Report / Period

6:00 am - NFIB optimism index - December
8:30 am - Producer price index - December
8:30 am - Core PPI - December

“There is only one side to the stock market, and it is not the bull side or the bear side, but the right side.”

― Edwin Lefèvre

Sourced in:
"Reminiscences of a Stock Operator’’, by Edwin Lefèvre, published in 1923.